Cancer remains one of the most formidable challenges in medicine, constantly evolving to evade treatment. Yet, in recent years, a breakthrough approach—anti-angiogenic therapy—has emerged as a powerful weapon against some of the most aggressive cancers, including kidney, lung, and colorectal cancer.
